{"title":"J&J’s COVID vaccine is dead in the US; FDA revokes authorization","link":"https://arstechnica.com/?p=1945919","date":1686086664000,"content":"<div>\n<figure>\n  <img src=\"https://cdn.arstechnica.net/wp-content/uploads/2021/04/GettyImages-1232239269-800x522.jpeg\" alt=\"Boxes of Johnson &amp; Johnson's Janssen COVID-19 vaccine at a vaccination site in Florida.\" />\n      <p><a href=\"https://cdn.arstechnica.net/wp-content/uploads/2021/04/GettyImages-1232239269.jpeg\">Enlarge</a> <span>/</span> Boxes of Johnson &amp; Johnson's Janssen COVID-19 vaccine at a vaccination site in Florida. (credit: <a href=\"https://www.gettyimages.com/detail/news-photo/johnson-johnson-covid-19-vaccine-boxes-are-seen-at-a-news-photo/1232239269?adppopup=true\">Getty | Paul Hennessy</a>)</p>  </figure>\n\n\n\n\n\n\n<div><a name=\"page-1\"></a></div>\n<p>The Food and Drug Administration has withdrawn authorization for Johnson &amp; Johnson's COVID-19 vaccine, ending its short-lived but troubled existence amid the pandemic.</p>\n<p>In <a href=\"https://www.fda.gov/media/169003/download\">a letter last week</a>, the FDA's top vaccine regulator, Peter Marks, wrote to Janssen Biotech—the Johnson &amp; Johnson-owned, Belgium-based company responsible for the vaccine—saying that the agency was revoking authorization. Marks opened the letter by noting that the withdrawal was at the request of the company.</p>\n<p>According to Marks, Janssen's May 22 letter informed the FDA that:</p></div><p><a href=\"https://arstechnica.com/?p=1945919#p3\">Read 7 remaining paragraphs</a> | <a href=\"https://arstechnica.com/?p=1945919&amp;comments=1\">Comments</a></p>","author":"Beth Mole","siteTitle":"Ars Technica","siteHash":"5b0ddf6e8923e49262a7894cfd77962733e43fbcc565a103b48373820b310636","entryHash":"959efa7bc7ccb26578dc075e82407ae6e2d5912b6852637700eeb91d01ea73a2","category":"Tech"}